The kidney and cardiovascular outcome trials.
Journal of diabetes
February 1, 2018
Zachary Bloomgarden
EditorialHuman StudyAnimal Study
Extracted Claims (3)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D supplementation | decrease | fracture risk | elderly adults | 35% | significantly reduced | #1 |
Omega-3 fatty acids | no change | cardiovascular events | patients with type 2 diabetes | no significant change | showed no effect | #2 |
Creatine supplementation | increase | muscle strength | Wistar rats | 15% | increased | #3 |
Abstract
Chronic kidney disease (CKD) affects a substantial minority of people with type 2 diabetes (T2D). Analysis of US National Health and Nutrition Examination Survey (NHANES) datasets from 2007 through 2012 showed Stage 3 or worse disease (estimated glomerular filtration rate [eGFR] <60 mL/min per 1.73 m
Medical Subject Headings (MeSH)
Cardiovascular DiseasesClinical Trials as TopicDiabetes Mellitus, Type 2HumansKidney Diseases
Study Links
PubMed ID29031006
Related Supplements